Controlling Fecal Incontinence With a Novel Anal Device

Can a novel anal insert achieve a clinically meaningful reduction in fecal incontinence (FI) severity compared to care as usual?In this randomized clinical trial that included 73 adults, a significant reduction in FI severity occurred in 25.7% of insert participants and 18.9% of control participants, with no significant difference between groups.This randomized clinical trial found that the novel anal insert was not beneficial on group level.

Corresponding Author: Sadé L. Assmann, MD, Institute of Nutrition and Translational Research in Metabolism, Maastricht Universitair Medisch Centrum+, P Debyelaan 25, Maastricht 6229HX, Netherlands (s.assmann@maastrichtuniversity.nl).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.